Dechra Pharmaceuticals

Pharmaceuticals

DPH.L

GBX 3,264 (1.6)%

Share price

$ 4.4 bn

Market Cap

$ 5.1 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.09x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Dechra Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 12 Kt (+0.57/+4.9% y-o-y). At the sime time, carbon intensity declined to 16 t (-1.8 /-10.1% y-o-y).

Dechra Pharmaceuticals's Scope 3 emissions was down at 1.9 Kt (-0.41 /-17.6% y-o-y). The decline accelerated compared to the CAGR of -7.2% since 2Q'19.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (location-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q2	12	7	5.3	1.9	761	16
2020Q2	12	6.7	5	2.3	654	18
2019Q2	9.2	5.5	3.7	2.4	636	15
2018Q2	7.5	3.8	3.6	1.7	530	14
2017Q2	7.9	4	3.9	1.6	478	17
2016Q2	6.6	3.4	3.1	1.5

Dechra Pharmaceuticals

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Dechra Pharmaceuticals's carbon footprint

Company environmental metrics